Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel compounds for cancer patented

May 30, 2012

Merck & Co. presents new phosphodiesterase 10A inhibitors

May 30, 2012

Japanese scientists discover novel protein kinase inhibitors

May 29, 2012

Scientists at Merck & Co. produce new mGlu5 receptor modulators

May 29, 2012

Novel potassium channel blockers disclosed by Merck & Co.

May 29, 2012

Novel arginase inhibitors prepared at Mars

May 29, 2012

New agents for respiratory and other disorders patented by RespiVert

May 29, 2012

Merck & Co. patents new hPDK1 inhibitors

May 29, 2012

Merck & Co. describes novel protein kinase inhibitors

May 25, 2012

Morphotek produces novel monoclonal antibodies for cancer

May 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...